About Biomodex
Biomodex is a company based in Paris (France) founded in 2014 was acquired by Mentice in January 2023.. Biomodex has raised $18.6 million across 2 funding rounds from investors including Idinvest Partners, Mentice and Innovation Capital. Biomodex offers products and services including Biorealistic Haptic Simulators and 3D Printed Models. Biomodex operates in a competitive market with competitors including eCential Robotics, SentiAR, Axial3D, Enhatch and inHEART, among others.
- Headquarter Paris, France
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomodex Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.6 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series A
May 31, 2018
-
Investors
Idinvest Partners
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Mentice
(Jan 22, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomodex
Biomodex offers a comprehensive portfolio of products and services, including Biorealistic Haptic Simulators and 3D Printed Models. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables realistic medical training with 3D models for procedure rehearsals
Facilitates patient-specific practice for advanced physician education quickly
Funding Insights of Biomodex
Biomodex has successfully raised a total of $18.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $15.0M
-
First Round
First Round
(16 Apr 2016)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series A - Biomodex | Valuation | Idinvest Partners | |
| Apr, 2016 | Amount | Series A - Biomodex | Valuation | Innovation Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biomodex
Biomodex has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Idinvest Partners, Mentice and Innovation Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are provided to low and middle market companies.
|
Founded Year | Domain | Location | |
|
Private equity investments are made in France and the US.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biomodex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biomodex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomodex Comparisons
Competitors of Biomodex
Biomodex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eCential Robotics, SentiAR, Axial3D, Enhatch and inHEART, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Robotic surgery platform for bone procedures is developed.
|
|
| domain | founded_year | HQ Location |
A 3D visualization platform is offered for interventional cardiac procedures.
|
|
| domain | founded_year | HQ Location |
Provider of cloud-based 3D-printed medical models and surgical guides
|
|
| domain | founded_year | HQ Location |
Provider of mobile enterprise apps for Salesforce
|
|
| domain | founded_year | HQ Location |
AI-based 3D cardiac models are developed for therapeutic planning.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomodex
Frequently Asked Questions about Biomodex
When was Biomodex founded?
Biomodex was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Biomodex located?
Biomodex is headquartered in Paris, France.
Is Biomodex a funded company?
Biomodex is a funded company, having raised a total of $18.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.6M, raised on Apr 16, 2016.
What does Biomodex do?
Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. The company uses techniques three-dimensional modeling and advanced 3D printers to produce exact copies of organs that can be used to train staff medical and under preoperative simulations. From biomedical imaging data of organs from MRI or scanners, the company has developed a process that helps to automate the creation of virtual 3D models of these organs which can then be printed using a 3D printer. Products are offered for bone drilling, soft tissue suturing, and medical device implantation and sizing, including pathology specifications, medical imaging segmentation, biomechanical modeling, organ 3D printing, simulation environment, and surgical simulation procedures. The company received an investment of 3.6M led by Innovation Capital to expand in the US.
Who are the top competitors of Biomodex?
Biomodex's top competitors include eCential Robotics, Axial3D and LensAR.
What products or services does Biomodex offer?
Biomodex offers Biorealistic Haptic Simulators and 3D Printed Models.
Who are Biomodex's investors?
Biomodex has 6 investors. Key investors include Idinvest Partners, Mentice, Innovation Capital, Allianz, and LBO France.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.